"© 2000-2014 Ingenuity Systems, Inc. All rights reserved."						Ingenuity Canonical Pathways	 -log(p-value)	Ratio	MoleculesRole of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	2.93E+01	2.48E-01	"MAP2K4,IL12A,TLR8,C1QA,CCL5,C1QB,IL6,EIF2S1,IFIH1,MBL2,TLR1,CREB1,CASP1,TLR7,C3,NLRP3,C5AR1,IL10,MAPK8,TLR9,TLR2,TLR4,TLR6,IL1B,TNF,C3AR1,PRKCB"Hepatic Fibrosis / Hepatic Stellate Cell Activation	2.88E+01	1.94E-01	"IGFBP4,IL1A,TGFBR1,MYL2,CCL5,IL6,IGF1,TIMP1,TGFB1,ECE1,TNFRSF1B,IL4,IFNG,CXCL9,TNFRSF1A,IL10,IL6R,IGFBP5,MMP2,IL1R1,TLR4,LY96,CSF1,IGFBP3,CCL21,TGFB3,CD14,IL1B,TNF,MMP9""Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis"	2.83E+01	1.14E-01	"MAP2K6,MAP2K4,IL1A,MMP3,AXIN1,CEBPD,TLR8,CCL5,IL6,FCGR1A,CCND1,MYC,TGFB1,TLR1,CREB1,TLR7,LTBR,NOS2,TNFRSF1B,FCGR3A,TNFSF11,C5AR1,TNFRSF1A,IL10,IL6R,STAT3,IL1R1,TLR9,IL7,TLR2,TLR4,FOS,IL1RN,CSF1,TLR6,IL1B,TNF,LRP1,PRKCB"Granulocyte Adhesion and Diapedesis	2.70E+01	1.70E-01	"IL1A,MMP3,CCL17,CCL5,CXCL10,Ccl8,CXCR2,Ccl2,MMP11,TNFRSF1B,CCL19,CXCL9,C5AR1,TNFRSF1A,Cxcl15,CXCR4,MMP2,IL1R1,CCL11,CXCL6,ITGB2,ITGAM,CCL4,CCL7,IL1RN,CCL21,CCL3L1/CCL3L3,IL1B,TNF,MMP9,HSPB1"Acute Phase Response Signaling	2.61E+01	1.66E-01	"MAP2K4,MAP2K6,SERPING1,FTL,IL1A,C3,TNFRSF1A,C1S,IL6R,MAPK8,VWF,SERPINA3,STAT3,IL1R1,IL6,PLG,C1R,C4A/C4B,FOS,HMOX1,MBL2,TF,IL1RN,CRP,CFB,IL1B,SERPINA1,TNFRSF1B,TNF,C2"Communication between Innate and Adaptive Immune Cells	2.53E+01	2.14E-01	"B2M,IFNG,IL1A,IL12A,IL10,TLR8,HLA-DRB1,IL6,CCL5,TLR9,CXCL10,TLR2,TLR4,CCL4,IL1RN,HLA-DRA,TLR1,TLR6,TLR7,FCER1G,CCL3L1/CCL3L3,IL1B,TNF,IL4"Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	2.45E+01	2.30E-01	"IFNG,TNFSF11,IL1A,IL12A,IL10,TLR8,HLA-DRB1,IL6,TLR9,TLR2,TLR4,IL1RN,CSF1,TGFB1,HLA-DRA,TLR1,TLR6,CCL21,TLR7,FCER1G,IL1B,TNF,IL4"Colorectal Cancer Metastasis Signaling	2.37E+01	1.19E-01	"MAP2K4,TGFBR1,MMP3,AXIN1,TLR8,IL6,CCND1,PTGER1,MYC,TGFB1,TLR1,TLR7,MMP11,NOS2,PTGER4,IFNG,TNFRSF1A,IL6R,MAPK8,MMP2,STAT3,TLR9,TLR2,TLR4,FOS,TLR6,TGFB3,PTGS2,JAK3,TNF,LRP1,MMP9"Agranulocyte Adhesion and Diapedesis	2.36E+01	1.51E-01	"IL1A,MYL2,MMP3,CCL17,CCL5,CXCL10,CXCR2,Ccl8,Ccl2,MMP11,CCL19,CXCL9,C5AR1,CXCR4,Cxcl15,TNFRSF1A,MMP2,IL1R1,CCL11,CXCL6,ITGB2,CCL4,CCL7,IL1RN,CCL21,CCL3L1/CCL3L3,IL1B,TNF,MMP9"LXR/RXR Activation	2.21E+01	1.73E-01	"APOE,IL1A,C3,MSR1,TNFRSF1A,CD36,IL6,IL1R1,ABCA1,C4A/C4B,TLR4,LY96,CCL7,TF,IL1RN,CD14,IL1B,S100A8,SERPINA1,PTGS2,TNFRSF1B,NOS2,TNF,MMP9"TREM1 Signaling	2.13E+01	2.22E-01	"TREM1,NLRP3,TYROBP,IL10,TLR8,IL6,STAT3,TLR9,FCGR2B,TLR2,TLR4,MPO,CCL7,TLR1,TLR6,CASP1,TLR7,IL1B,TNF,ITGAX"Dendritic Cell Maturation	2.04E+01	1.23E-01	"MAP2K4,B2M,IL1A,IL12A,TYROBP,TNFRSF1A,FCGR2A,IL10,MAPK8,HLA-DRB1,IL6,TLR9,TREM2,FCGR2B,FCGR1A,TLR2,TLR4,IL1RN,CREB1,HLA-DRA,FCER1G,IL1B,LTBR,TNFRSF1B,TNF,FCGR3A" 	1.91E+01	2.31E-01	"CCR1,MAP2K4,MAP2K6,IL1A,IL10,FCGR2A,MAPK8,IL6,STAT3,IL1R1,FCGR2B,HMOX1,FOS,IL1RN,IL10RB,CD14,IL1B,TNF"T Helper Cell Differentiation	1.75E+01	2.36E-01	"IFNG,STAT6,IL12A,TGFBR1,TNFRSF1A,IL10,IL6R,HLA-DRB1,IL6,STAT3,TGFB1,HLA-DRA,IL10RB,FCER1G,TNFRSF1B,TNF,IL4""Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis"	1.69E+01	1.00E-01	"MAP2K4,MAP2K6,IFNG,TNFSF11,ADAM17,IL1A,MMP3,TNFRSF1A,IL10,AXIN1,MAPK8,IL1R1,IL6,IL7,CSF1R,FOS,IGF1,CSF1,IL1RN,TGFB1,IL1B,TNFRSF1B,TNF,LRP1,IL4"Complement System	1.66E+01	3.71E-01	"C4A/C4B,C1R,SERPING1,MBL2,C5AR1,MASP2,C3,C1S,CFB,C1QA,C1QB,C3AR1,C2"NF-κB Signaling	1.60E+01	1.22E-01	"MAP2K6,TNFSF11,IL1A,TGFBR1,TNFRSF1A,TLR8,MAPK8,IL1R1,TLR9,TLR2,TLR4,IL1RN,TLR1,TLR6,TLR7,FCER1G,IL1B,LTBR,CASP8,TNFRSF1B,TNF,PRKCB"Atherosclerosis Signaling	1.55E+01	1.37E-01	"IFNG,APOE,IL1A,MSR1,MMP3,CXCR4,CD36,IL6,CCL11,ITGB2,IL1RN,TGFB1,CSF1,IL1B,S100A8,SERPINA1,ALOX5,TNF,MMP9"IL-6 Signaling	1.47E+01	1.45E-01	"MAP2K4,MAP2K6,IL1A,TNFRSF1A,HSPB2,IL6R,MAPK8,IL6,STAT3,IL1R1,FOS,IL1RN,CRP,CD14,IL1B,TNFRSF1B,TNF,HSPB1"p38 MAPK Signaling	1.46E+01	1.50E-01	"MAP2K4,MAP2K6,IL1A,TGFBR1,TNFRSF1A,HSPB2,IL1R1,MEF2B,MYC,IL1RN,TGFB1,CREB1,TGFB3,IL1B,MEF2C,TNFRSF1B,TNF,HSPB1"Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	1.45E+01	9.91E-02	"MAP2K4,IFNG,APOE,PTPN6,TNFRSF1A,PPP2CA,MAPK8,TLR2,FOS,TLR4,NCF1,MPO,CAT,S100A8,SERPINA1,TNFRSF1B,NOS2,JAK3,TNF,IL4,PRKCB"IL-12 Signaling and Production in Macrophages	1.36E+01	1.15E-01	"MAP2K4,IFNG,STAT6,APOE,IL12A,IL10,MAPK8,TLR2,FOS,TLR4,TGFB1,TGFB3,S100A8,SERPINA1,NOS2,TNF,IL4,PRKCB"Toll-like Receptor Signaling	1.31E+01	2.03E-01	"TLR2,MAP2K6,MAP2K4,FOS,TLR4,LY96,TLR6,TLR1,TLR7,MAPK8,TLR8,CD14,TLR9"Glucocorticoid Receptor Signaling	1.22E+01	7.36E-02	"MAP2K4,IFNG,TGFBR1,IL10,MAPK8,IL6,STAT3,CCL5,CCL11,CD163,FCGR1A,FOS,TGFB1,IL1RN,CREB1,TGFB3,IL1B,PTGS2,NOS2,JAK3,TNF,IL4"Neuroprotective Role of THOP1 in Alzheimer's Disease	1.21E+01	2.00E-01	"MME,PLG,IFNG,ECE2,CREB1,SERPINA3,ECE1,IDE,MMP9,ACE,APP"Type I Diabetes Mellitus Signaling	1.16E+01	1.24E-01	"MAP2K4,MAP2K6,IFNG,IL12A,TNFRSF1A,MAPK8,HLA-DRB1,IL1R1,HLA-DRA,FCER1G,IL1B,NOS2,CASP8,TNFRSF1B,TNF"Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	1.16E+01	2.39E-01	"CXCL10,CCR1,IFNG,IL1A,IL12A,CCL4,IL1RN,IL1B,CCL5,IL6,TNF"Crosstalk between Dendritic Cells and Natural Killer Cells	1.16E+01	1.32E-01	"TLR4,IFNG,IL12A,TYROBP,HLA-DRA,TLR7,HLA-DRB1,LTBR,IL6,TNFRSF1B,TLR9,TREM2,TNF,IL4"Hepatic Cholestasis	1.00E+01	8.20E-02	"MAP2K4,TLR4,IFNG,LY96,IL1A,IL1RN,TNFRSF1A,MAPK8,CD14,IL1B,IL1R1,IL6,TNFRSF1B,TNF,PRKCB"Differential Regulation of Cytokine Production in Intestinal Epithelial Cells by IL-17A and IL-17F	9.86E+00	3.48E-01	"IFNG,IL1A,IL12A,CCL4,IL10,IL1B,CCL5,TNF"Chemokine Signaling	9.32E+00	1.47E-01	"FOS,CCL4,CCL7,MYL2,CFL1,CXCR4,MAPK8,CCL5,CCL11,LIMK1,PRKCB"IL-8 Signaling	9.12E+00	7.11E-02	"MAP2K4,MYL2,MAPK8,MMP2,CCND1,LIMK1,FOS,ITGB2,HMOX1,ITGAM,MPO,CXCR2,PTGS2,MMP9,ITGAX,PRKCB"ILK Signaling	9.12E+00	7.80E-02	"MAP2K4,MAP2K6,CFL1,MYL2,PPP2CA,TNFRSF1A,MAPK8,CCND1,MYC,FOS,ITGB2,CREB1,PTGS2,NOS2,TNF,MMP9"IL-17 Signaling	9.11E+00	1.47E-01	"MAP2K4,CXCL10,MAP2K6,MMP3,TIMP1,CRP,MAPK8,PTGS2,IL6,NOS2,CCL11"Role of Cytokines in Mediating Communication between Immune Cells	9.11E+00	1.82E-01	"IFNG,IL1A,IL12A,IL10,IL1RN,TGFB1,IL1B,IL6,TNF,IL4"Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F	9.08E+00	3.89E-01	"IL12A,CCL4,IL10,IL1B,CCL5,IL6,TNF"HMGB1 Signaling	9.01E+00	1.10E-01	"MAP2K4,MAP2K6,TLR4,IFNG,FOS,IL1A,TNFRSF1A,MAPK8,IL1R1,TNFRSF1B,TNF,PLAT"Systemic Lupus Erythematosus Signaling	8.91E+00	6.67E-02	"IL1A,PTPN6,IL10,FCGR2A,IL6R,IL6,FCGR2B,TLR9,FCGR1A,PTPRC,FOS,IL1RN,TLR7,FCER1G,IL1B,TNF,FCGR3A"MSP-RON Signaling Pathway	8.64E+00	1.76E-01	"TLR2,ITGB2,TLR4,IFNG,ITGAM,IL12A,CSF1,NOS2,TNF"Cholecystokinin/Gastrin-mediated Signaling	8.59E+00	1.13E-01	"MAP2K4,MAP2K6,FOS,IL1A,IL1RN,MAPK8,IL1B,MEF2C,PTGS2,TNF,MEF2B,PRKCB"Graft-versus-Host Disease Signaling	8.55E+00	1.76E-01	"IFNG,IL1A,IL1RN,HLA-DRA,FCER1G,HLA-DRB1,IL1B,IL6,TNF"Aryl Hydrocarbon Receptor Signaling	7.94E+00	7.60E-02	"MYC,FOS,CTSD,IL1A,TGFB1,HSPB2,TGFB3,MAPK8,IL1B,IL6,TNF,CCND1,HSPB1"Inhibition of Matrix Metalloproteases	7.83E+00	2.00E-01	"ADAM17,MMP3,TIMP1,ADAM10,MMP2,MMP11,MMP9,LRP1"MIF Regulation of Innate Immunity	7.65E+00	1.54E-01	"MAP2K4,TLR4,FOS,LY96,MAPK8,CD14,PTGS2,NOS2"Pathogenesis of Multiple Sclerosis	7.58E+00	5.00E-01	"CXCL10,CCR1,CXCL9,CCL4,CCL5"VDR/RXR Activation	7.57E+00	1.14E-01	"CXCL10,IFNG,TNFSF11,IL12A,IGFBP3,CD14,IGFBP5,CCL5,CALB1,PRKCB"Role of IL-17F in Allergic Inflammatory Airway Diseases	7.31E+00	1.67E-01	"CXCL10,CCL4,IGF1,CCL7,CREB1,IL1B,IL6,CXCL6"Pancreatic Adenocarcinoma Signaling	7.26E+00	8.59E-02	"MAP2K4,HMOX1,TGFBR1,TGFB1,MAPK8,TGFB3,STAT3,PTGS2,JAK3,CCND1,MMP9"LPS/IL-1 Mediated Inhibition of RXR Function	7.22E+00	6.12E-02	"MAP2K4,APOE,IL1A,TNFRSF1A,MAPK8,IL1R1,ABCA1,TLR4,LY96,IL1RN,CAT,CD14,IL1B,TNFRSF1B,TNF"Huntington's Disease Signaling	7.17E+00	5.95E-02	"MAP2K4,BDNF,GLS,CLTC,MAPK8,CTSD,IGF1,CREB1,CASP1,DLG4,UBC,CASP8,DNM1L,SNCA,PRKCB"Hematopoiesis from Pluripotent Stem Cells	6.87E+00	1.27E-01	"IL1A,IL12A,CSF1,IL10,FCER1G,IL6,IL7,IL4"PPARα/RXRα Activation	6.72E+00	6.50E-02	"MAP2K6,MAP2K4,TGFBR1,TGFB1,TGFB3,CD36,MAPK8,IL1B,MEF2C,IL6,IL1R1,ABCA1,PRKCB"Role of IL-17A in Arthritis	6.67E+00	1.25E-01	"MAP2K4,MAP2K6,CCL7,MAPK8,CCL5,PTGS2,NOS2,CXCL6"Germ Cell-Sertoli Cell Junction Signaling	6.47E+00	7.10E-02	"MAP2K4,MAP2K6,TUBB3,TGFBR1,AXIN1,TGFB1,TNFRSF1A,MAPK8,TGFB3,TUBB,TNF,LIMK1"IL-17A Signaling in Gastric Cells	6.43E+00	2.14E-01	"MAP2K4,CXCL10,FOS,MAPK8,CCL5,TNF"Death Receptor Signaling	6.42E+00	1.18E-01	"MAP2K4,TNFRSF1A,HSPB2,MAPK8,TNFRSF1B,CASP8,TNF,HSPB1"Role of PKR in Interferon Induction and Antiviral Response	6.41E+00	1.43E-01	"MAP2K6,IFNG,TNFRSF1A,CASP8,EIF2S1,FCGR1A,TNF"Cardiac Hypertrophy Signaling	6.31E+00	5.60E-02	"MAP2K4,MAP2K6,TGFBR1,MYL2,IL6R,MAPK8,IL6,MEF2B,IGF1,TGFB1,CREB1,TGFB3,MEF2C,HSPB1"iNOS Signaling	6.12E+00	1.32E-01	"TLR4,IFNG,FOS,LY96,CD14,NOS2,JAK3"Corticotropin Releasing Hormone Signaling	6.04E+00	6.90E-02	"FOS,BDNF,CREB1,CRH,MEF2C,PTGS2,CRHR1,NOS2,MEF2B,PRKCB"14-3-3-mediated Signaling	5.90E+00	8.26E-02	"MAP2K4,FOS,TUBB3,TNFRSF1A,MAPK8,GFAP,TUBB,TNF,SNCA,PRKCB"Role of MAPK Signaling in the Pathogenesis of Influenza	5.88E+00	1.11E-01	"MAP2K4,CXCL10,MAP2K6,IFNG,MAPK8,CCL5,PTGS2,TNF"Regulation of the Epithelial-Mesenchymal Transition Pathway	5.78E+00	6.12E-02	"MAP2K4,MAP2K6,ADAM17,TGFBR1,AXIN1,TGFB1,EGR1,TGFB3,MMP2,STAT3,JAK3,MMP9"PPAR Signaling	5.77E+00	8.41E-02	"FOS,IL1A,IL1RN,TNFRSF1A,IL1B,IL1R1,PTGS2,TNFRSF1B,TNF"LPS-stimulated MAPK Signaling	5.64E+00	9.64E-02	"MAP2K4,MAP2K6,TLR4,FOS,CREB1,MAPK8,CD14,PRKCB"Tec Kinase Signaling	5.60E+00	5.98E-02	"MAP2K4,TLR4,STAT6,FOS,MAPK8,HCK,FCER1G,STAT3,JAK3,TNF,PRKCB"Inhibition of Angiogenesis by TSP1	5.59E+00	1.43E-01	"MAP2K4,TGFBR1,TGFB1,MAPK8,CD36,MMP9"Leukocyte Extravasation Signaling	5.37E+00	5.71E-02	"MAP2K4,ITGB2,NCF1,ITGAM,MMP3,CXCR4,TIMP1,MAPK8,MMP2,MMP11,MMP9,PRKCB"Ceramide Signaling	5.34E+00	8.79E-02	"MAP2K4,CTSD,FOS,PPP2CA,TNFRSF1A,MAPK8,TNFRSF1B,TNF"Renin-Angiotensin Signaling	5.24E+00	7.14E-02	"MAP2K4,FOS,PTPN6,MAPK8,STAT3,CCL5,TNF,ACE,PRKCB"Induction of Apoptosis by HIV1	5.23E+00	1.04E-01	"MAP2K4,CXCR4,TNFRSF1A,MAPK8,TNFRSF1B,CASP8,TNF"Allograft Rejection Signaling	5.21E+00	8.25E-02	"B2M,IFNG,IL10,HLA-DRA,FCER1G,HLA-DRB1,TNF,IL4"Endothelin-1 Signaling	5.19E+00	5.73E-02	"MYC,HMOX1,FOS,ECE2,CASP1,MAPK8,ECE1,PTGS2,CASP8,NOS2,PRKCB"Activation of IRF by Cytosolic Pattern Recognition Receptors	5.04E+00	9.59E-02	"MAP2K4,IFIH1,IL10,ZBP1,MAPK8,IL6,TNF"Role of JAK family kinases in IL-6-type Cytokine Signaling	5.02E+00	1.79E-01	"MAP2K4,IL6R,MAPK8,STAT3,IL6"NRF2-mediated Oxidative Stress Response	5.00E+00	5.64E-02	"MAP2K4,MAP2K6,HMOX1,FOS,FTL,SOD1,CAT,MAPK8,MAFK,MAFF,PRKCB"IL-17A Signaling in Airway Cells	4.99E+00	9.21E-02	"MAP2K4,MAPK8,STAT3,IL6,CCL11,JAK3,CXCL6"Factors Promoting Cardiogenesis in Vertebrates	4.99E+00	8.08E-02	"TGFBR1,MYL2,AXIN1,TGFB1,TGFB3,MEF2C,LRP1,PRKCB"Role of NFAT in Cardiac Hypertrophy	4.96E+00	5.26E-02	"MAP2K4,MAP2K6,TGFBR1,IGF1,TGFB1,MAPK8,TGFB3,MEF2C,IL6,MEF2B,PRKCB"TNFR2 Signaling	4.76E+00	1.47E-01	"MAP2K4,FOS,MAPK8,TNFRSF1B,TNF"TNFR1 Signaling	4.74E+00	1.11E-01	"MAP2K4,FOS,TNFRSF1A,MAPK8,CASP8,TNF"CCR5 Signaling in Macrophages	4.73E+00	7.22E-02	"MAP2K4,FOS,CCL4,MAPK8,FCER1G,CCL5,PRKCB"IGF-1 Signaling	4.71E+00	7.48E-02	"IGFBP4,FOS,IGF1,MAPK8,IGFBP3,IGFBP5,STAT3,IGFBP2"B Cell Receptor Signaling	4.71E+00	5.71E-02	"MAP2K4,MAP2K6,PTPRC,PTPN6,FCGR2A,EGR1,CREB1,MAPK8,FCGR2B,PRKCB"Xenobiotic Metabolism Signaling	4.67E+00	4.51E-02	"MAP2K6,MAP2K4,HMOX1,IL1A,FTL,PPP2CA,CAT,MAPK8,IL1B,IL6,NOS2,TNF,PRKCB"Cdc42 Signaling	4.66E+00	5.38E-02	"MAP2K4,B2M,FOS,MYL2,CFL1,HLA-DRA,MAPK8,FCER1G,HLA-DRB1,LIMK1"HGF Signaling	4.62E+00	7.21E-02	"MAP2K4,FOS,MAPK8,STAT3,PTGS2,IL6,CCND1,PRKCB"Mitochondrial Dysfunction	4.54E+00	4.65E-02	"MAP2K4,CAT,MAPK8,LRRK2,BACE1,CASP8,SNCA,APP,PINK1,AIFM1"PDGF Signaling	4.46E+00	8.14E-02	"MAP2K4,MYC,FOS,MAPK8,STAT3,JAK3,PRKCB"Role of NFAT in Regulation of the Immune Response	4.43E+00	5.00E-02	"FOS,FCGR2A,HLA-DRA,FCER1G,HLA-DRB1,MEF2C,FCGR2B,FCGR1A,FCGR3A,MEF2B"Wnt/β-catenin Signaling	4.43E+00	5.71E-02	"MYC,TGFBR1,PPP2CA,AXIN1,TGFB1,SOX10,TGFB3,UBC,CCND1,LRP1"Molecular Mechanisms of Cancer	4.23E+00	3.61E-02	"MYC,MAP2K6,MAP2K4,FOS,TGFBR1,TGFB1,AXIN1,TGFB3,MAPK8,JAK3,CASP8,CCND1,LRP1,PRKCB"Axonal Guidance Signaling	4.23E+00	3.29E-02	"ADAM17,TUBB3,CFL1,MYL2,BDNF,CXCR4,MMP2,TUBB,LIMK1,IGF1,ECE2,ADAM10,MMP11,ACE,MMP9,PRKCB"CD28 Signaling in T Helper Cells	4.15E+00	5.88E-02	"MAP2K4,PTPRC,FOS,PTPN6,HLA-DRA,MAPK8,FCER1G,HLA-DRB1"FXR/RXR Activation	4.15E+00	6.36E-02	"MAP2K4,APOE,IL1A,IL1RN,MAPK8,IL1B,TNF"Clathrin-mediated Endocytosis Signaling	4.15E+00	5.05E-02	"ITGB2,APOE,IGF1,TF,CLTC,SERPINA1,S100A8,DNM1L,UBC,SNAP91"TGF-β Signaling	4.12E+00	7.45E-02	"MAP2K4,MAP2K6,FOS,TGFBR1,TGFB1,MAPK8,TGFB3"Apoptosis Signaling	4.09E+00	7.00E-02	"MAP2K4,TNFRSF1A,MAPK8,TNFRSF1B,CASP8,TNF,AIFM1"Tight Junction Signaling	4.06E+00	5.39E-02	"FOS,TGFBR1,MYL2,PPP2CA,TGFB1,TNFRSF1A,TGFB3,TNFRSF1B,TNF"Airway Pathology in Chronic Obstructive Pulmonary Disease	4.06E+00	2.73E-01	"MMP2,TNF,MMP9"CD40 Signaling	4.01E+00	8.45E-02	"MAP2K4,MAP2K6,FOS,MAPK8,STAT3,JAK3"Eicosanoid Signaling	4.01E+00	6.98E-02	"ALOX5AP,PTGS2,PTGDS,ALOX5,PTGER4,PTGER1"Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes	3.94E+00	6.60E-02	"HMOX1,NCF1,FCGR2A,HCK,FCGR1A,FCGR3A,PRKCB"JAK/Stat Signaling	3.86E+00	8.45E-02	"STAT6,FOS,PTPN6,STAT3,IL6,JAK3"PI3K Signaling in B Lymphocytes	3.85E+00	5.59E-02	"PTPRC,TLR4,FOS,C3,CREB1,FCGR2B,IL4,PRKCB"Neurotrophin/TRK Signaling	3.82E+00	7.89E-02	"MAP2K4,MAP2K6,FOS,BDNF,CREB1,MAPK8"Macropinocytosis Signaling	3.82E+00	7.79E-02	"MRC1,ITGB2,CSF1,CD14,CSF1R,PRKCB"GNRH Signaling	3.81E+00	5.23E-02	"MAP2K4,MAP2K6,FOS,EGR1,CREB1,MAPK8,DNM1L,PRKCB"Growth Hormone Signaling	3.79E+00	7.69E-02	"FOS,PTPN6,IGF1,IGFBP3,STAT3,PRKCB"IL-22 Signaling	3.78E+00	1.60E-01	"MAP2K4,IL10RB,MAPK8,STAT3"STAT3 Pathway	3.65E+00	7.50E-02	"MAP2K4,MYC,PTPN6,TGFBR1,MAPK8,STAT3"Autoimmune Thyroid Disease Signaling	3.65E+00	8.06E-02	"IL10,HLA-DRA,FCER1G,HLA-DRB1,IL4"IL-4 Signaling	3.62E+00	7.50E-02	"STAT6,PTPN6,HLA-DRA,HLA-DRB1,JAK3,IL4"Sertoli Cell-Sertoli Cell Junction Signaling	3.59E+00	4.55E-02	"MAP2K4,TUBB3,AXIN1,TNFRSF1A,MAPK8,TGFB3,TUBB,NOS2,TNF"Acute Myeloid Leukemia Signaling	3.53E+00	7.14E-02	"MAP2K4,MAP2K6,MYC,STAT3,CCND1,CSF1R"Fc Epsilon RI Signaling	3.51E+00	5.98E-02	"MAP2K4,MAP2K6,MAPK8,FCER1G,TNF,IL4,PRKCB"Hematopoiesis from Multipotent Stem Cells	3.48E+00	2.50E-01	"CSF1,IL7,IL4"CD27 Signaling in Lymphocytes	3.48E+00	8.47E-02	"MAP2K4,MAP2K6,FOS,MAPK8,CASP8"Reelin Signaling in Neurons	3.47E+00	7.06E-02	"MAP2K4,ITGB2,APOE,MAPK8,HCK,APP"Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	3.47E+00	6.74E-02	"MAP2K4,FOS,TGFBR1,TGFB1,MAPK8,TGFB3"Role of IL-17A in Psoriasis	3.37E+00	2.14E-01	"S100A9,S100A8,CXCL6"Type II Diabetes Mellitus Signaling	3.34E+00	4.09E-02	"MAP2K4,TNFRSF1A,MAPK8,CD36,TNFRSF1B,TNF,PRKCB"B Cell Development	3.28E+00	1.11E-01	"PTPRC,HLA-DRA,HLA-DRB1,IL7"Superpathway of Citrulline Metabolism	3.27E+00	7.89E-02	"GLS,NOS2,ARG1"OX40 Signaling Pathway	3.27E+00	6.19E-02	"MAP2K4,B2M,HLA-DRA,MAPK8,FCER1G,HLA-DRB1"MIF-mediated Glucocorticoid Regulation	3.23E+00	9.52E-02	"TLR4,LY96,CD14,PTGS2"Myc Mediated Apoptosis Signaling	3.22E+00	7.94E-02	"MAP2K4,MYC,IGF1,MAPK8,CASP8"PAK Signaling	3.21E+00	5.45E-02	"MAP2K4,MYL2,CFL1,MAPK8,TNF,LIMK1"Bladder Cancer Signaling	3.19E+00	6.19E-02	"MYC,MMP3,MMP2,MMP11,CCND1,MMP9"Coagulation System	3.13E+00	1.05E-01	"PLG,VWF,SERPINA1,PLAT"IL-17A Signaling in Fibroblasts	3.13E+00	1.00E-01	"FOS,CCL7,CEBPD,IL6"IL-1 Signaling	3.09E+00	5.50E-02	"MAP2K4,MAP2K6,FOS,IL1A,MAPK8,IL1R1"Role of JAK1 and JAK3 in γc Cytokine Signaling	3.09E+00	7.35E-02	"STAT6,STAT3,JAK3,IL7,IL4"Airway Inflammation in Asthma	3.09E+00	3.33E-01	"TNF,IL4"Antigen Presentation Pathway	3.04E+00	9.52E-02	"B2M,IFNG,HLA-DRA,HLA-DRB1"ERK5 Signaling	3.02E+00	7.35E-02	"MYC,FOS,CREB1,MEF2C,MEF2B"Amyotrophic Lateral Sclerosis Signaling	2.95E+00	4.76E-02	"PRPH,GRIN2A,SOD1,IGF1,CAT,CASP1"Ephrin Receptor Signaling	2.94E+00	3.81E-02	"GRIN2A,CFL1,CXCR4,AXIN1,CREB1,ADAM10,STAT3,LIMK1"Thyroid Cancer Signaling	2.91E+00	9.09E-02	"CXCL10,MYC,BDNF,CCND1"HIF1α Signaling	2.86E+00	5.36E-02	"MMP3,MAPK8,MMP2,MMP11,NOS2,MMP9"UVC-Induced MAPK Signaling	2.83E+00	9.09E-02	"MAP2K4,FOS,MAPK8,PRKCB"IL-3 Signaling	2.82E+00	6.67E-02	"STAT6,FOS,PTPN6,STAT3,PRKCB"ERK/MAPK Signaling	2.75E+00	3.79E-02	"MYC,FOS,PPP2CA,HSPB2,CREB1,STAT3,HSPB1,PRKCB"Caveolar-mediated Endocytosis Signaling	2.74E+00	5.88E-02	"B2M,ITGB2,ITGAM,Cd55/Daf2,ITGAX"Phospholipase C Signaling	2.72E+00	3.40E-02	"HMOX1,MYL2,FCGR2A,CREB1,FCER1G,MEF2C,FCGR2B,MEF2B,PRKCB"Natural Killer Cell Signaling	2.71E+00	5.08E-02	"PTPN6,FCGR2A,TYROBP,FCER1G,FCGR3A,PRKCB"Superoxide Radicals Degradation	2.70E+00	2.50E-01	"SOD1,CAT"Role of Tissue Factor in Cancer	2.69E+00	4.62E-02	"CFL1,CSF1,EGR1,HCK,IL1B,LIMK1"CXCR4 Signaling	2.64E+00	4.02E-02	"MAP2K4,FOS,MYL2,CXCR4,EGR1,MAPK8,PRKCB"PKCθ Signaling in T Lymphocytes	2.59E+00	4.17E-02	"MAP2K4,FOS,HLA-DRA,MAPK8,FCER1G,HLA-DRB1""Role of JAK1, JAK2 and TYK2 in Interferon Signaling"	2.56E+00	1.07E-01	"IFNG,PTPN6,STAT3"P2Y Purigenic Receptor Signaling Pathway	2.49E+00	4.17E-02	"MYC,FOS,P2RY6,CREB1,P2RY12,PRKCB"ErbB Signaling	2.48E+00	5.56E-02	"MAP2K4,MAP2K6,FOS,MAPK8,PRKCB"Antiproliferative Role of TOB in T Cell Signaling	2.46E+00	1.15E-01	"TGFBR1,TGFB1,TGFB3"FGF Signaling	2.46E+00	5.32E-02	"MAP2K6,PTPN6,CREB1,MAPK8,STAT3"UVB-Induced MAPK Signaling	2.45E+00	6.90E-02	"MAP2K4,FOS,MAPK8,PRKCB"RANK Signaling in Osteoclasts	2.43E+00	5.15E-02	"MAP2K4,MAP2K6,FOS,TNFSF11,MAPK8"Citrulline Biosynthesis	2.43E+00	7.69E-02	"GLS,ARG1"CTLA4 Signaling in Cytotoxic T Lymphocytes	2.41E+00	5.21E-02	"B2M,PTPN6,PPP2CA,CLTC,FCER1G"Thrombopoietin Signaling	2.40E+00	6.25E-02	"MYC,FOS,STAT3,PRKCB"EGF Signaling	2.37E+00	6.25E-02	"MAP2K4,FOS,MAPK8,STAT3"ErbB2-ErbB3 Signaling	2.34E+00	6.35E-02	"MYC,STAT3,JAK3,CCND1"Prostanoid Biosynthesis	2.33E+00	1.33E-01	"PTGS2,PTGDS"Glioma Invasiveness Signaling	2.31E+00	6.06E-02	"PLG,TIMP1,MMP2,MMP9"RAR Activation	2.29E+00	3.59E-02	"MAP2K4,FOS,TGFB1,MAPK8,IGFBP3,TGFB3,PRKCB"Chronic Myeloid Leukemia Signaling	2.29E+00	4.72E-02	"MYC,TGFBR1,TGFB1,TGFB3,CCND1"IL-15 Signaling	2.24E+00	5.56E-02	"STAT6,STAT3,JAK3,IL4"Calcium-induced T Lymphocyte Apoptosis	2.21E+00	5.63E-02	"HLA-DRA,FCER1G,HLA-DRB1,PRKCB"Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	2.20E+00	7.69E-02	"B2M,FCER1G,CASP8"Estrogen-Dependent Breast Cancer Signaling	2.19E+00	5.48E-02	"FOS,IGF1,CREB1,CCND1"GM-CSF Signaling	2.19E+00	5.88E-02	"HCK,STAT3,CCND1,PRKCB"Synaptic Long Term Depression	2.18E+00	3.70E-02	"IGF1,PPP2CA,CRH,CRHR1,NOS2,PRKCB"Neuropathic Pain Signaling In Dorsal Horn Neurons	2.18E+00	4.59E-02	"FOS,GRIN2A,BDNF,CREB1,PRKCB"Paxillin Signaling	2.16E+00	4.27E-02	"MAP2K4,ITGB2,ITGAM,MAPK8,ITGAX"IL-9 Signaling	2.13E+00	7.50E-02	"STAT3,JAK3,TNF"Oncostatin M Signaling	2.13E+00	8.57E-02	"MMP3,STAT3,JAK3"Pyridoxal 5'-phosphate Salvage Pathway	2.11E+00	5.26E-02	"MAP2K4,MAP2K6,MAPK8,LIMK1"Cell Cycle: G1/S Checkpoint Regulation	2.11E+00	5.56E-02	"MYC,TGFB1,TGFB3,CCND1"GDNF Family Ligand-Receptor Interactions	2.07E+00	5.26E-02	"MAP2K4,FOS,CREB1,MAPK8"April Mediated Signaling	2.00E+00	6.82E-02	"MAP2K4,FOS,MAPK8"Gαs Signaling	1.98E+00	4.00E-02	"MSR1,CREB1,HCK,CRHR1,PTGER4"Prolactin Signaling	1.96E+00	4.76E-02	"MYC,FOS,STAT3,PRKCB"Ephrin B Signaling	1.94E+00	4.88E-02	"CFL1,CXCR4,AXIN1,LIMK1"B Cell Activating Factor Signaling	1.94E+00	6.52E-02	"MAP2K4,FOS,MAPK8"G-Protein Coupled Receptor Signaling	1.93E+00	2.90E-02	"CCR4,CXCR2,CREB1,P2RY12,STAT3,CRHR1,PTGER4,PRKCB"Melatonin Degradation III	1.93E+00	1.67E-01	MPOFcγRIIB Signaling in B Lymphocytes	1.91E+00	4.69E-02	"MAP2K4,MAPK8,FCGR2B"HER-2 Signaling in Breast Cancer	1.90E+00	4.88E-02	"ITGB2,MMP2,CCND1,PRKCB"Gα12/13 Signaling	1.89E+00	3.94E-02	"MAP2K4,MYL2,MAPK8,MEF2C,MEF2B"Cyclins and Cell Cycle Regulation	1.83E+00	4.17E-02	"PPP2CA,TGFB1,TGFB3,CCND1"Parkinson's Signaling	1.83E+00	1.05E-01	"MAPK8,SNCA"Protein Kinase A Signaling	1.81E+00	2.44E-02	"PTPRC,TH,PTPN6,TGFBR1,MYL2,TGFB1,CREB1,TGFB3,PTGS2,PRKCB"cAMP-mediated signaling	1.80E+00	3.10E-02	"CCR4,CXCR2,CREB1,P2RY12,STAT3,CRHR1,PTGER4"nNOS Signaling in Neurons	1.75E+00	5.77E-02	"GRIN2A,DLG4,PRKCB"Endoplasmic Reticulum Stress Pathway	1.73E+00	1.05E-01	"MAPK8,EIF2S1"Ephrin A Signaling	1.72E+00	5.56E-02	"CFL1,ADAM10,LIMK1"Neuregulin Signaling	1.69E+00	3.85E-02	"MYC,ADAM17,DLG4,PRKCB"Ovarian Cancer Signaling	1.68E+00	3.29E-02	"AXIN1,MMP2,PTGS2,CCND1,MMP9"Virus Entry via Endocytic Pathways	1.68E+00	3.96E-02	"B2M,ITGB2,CLTC,PRKCB"Human Embryonic Stem Cell Pluripotency	1.66E+00	3.09E-02	"TGFBR1,BDNF,AXIN1,TGFB1,TGFB3"Signaling by Rho Family GTPases	1.65E+00	2.61E-02	"MAP2K4,FOS,MYL2,CFL1,MAPK8,GFAP,LIMK1"Cardiomyocyte Differentiation via BMP Receptors	1.64E+00	8.70E-02	"MYL2,MEF2C"Endometrial Cancer Signaling	1.63E+00	5.00E-02	"MYC,AXIN1,CCND1"Guanine and Guanosine Salvage I	1.63E+00	1.11E-01	HPRT1Glutamine Degradation I	1.63E+00	2.00E-01	GLSIL-2 Signaling	1.61E+00	4.92E-02	"FOS,MAPK8,JAK3"Mouse Embryonic Stem Cell Pluripotency	1.58E+00	4.04E-02	"MYC,AXIN1,STAT3,JAK3"Salvage Pathways of Pyrimidine Ribonucleotides	1.58E+00	3.54E-02	"MAP2K4,MAP2K6,MAPK8,LIMK1"Nur77 Signaling in T Lymphocytes	1.57E+00	4.69E-02	"HLA-DRA,FCER1G,HLA-DRB1"Antioxidant Action of Vitamin C	1.55E+00	3.60E-02	"MAP2K4,HMOX1,MAPK8,TNF"T Cell Receptor Signaling	1.55E+00	3.67E-02	"MAP2K4,PTPRC,FOS,MAPK8"Integrin Signaling	1.53E+00	2.88E-02	"MAP2K4,ITGB2,ITGAM,MYL2,MAPK8,ITGAX"Gluconeogenesis I	1.53E+00	4.26E-02	"PGK1,GAPDH"Tumoricidal Function of Hepatic Natural Killer Cells	1.49E+00	7.41E-02	"CASP8,AIFM1"Estrogen-mediated S-phase Entry	1.49E+00	7.14E-02	"MYC,CCND1"Glycolysis I	1.49E+00	4.88E-02	"PGK1,GAPDH"Glutamate Receptor Signaling	1.49E+00	4.17E-02	"GRIN2A,GLS,DLG4"ATM Signaling	1.47E+00	4.55E-02	"MAP2K4,CREB1,MAPK8"Rac Signaling	1.46E+00	3.12E-02	"MAP2K4,CFL1,MAPK8,LIMK1"NADH Repair	1.46E+00	1.11E-01	GAPDHThyroid Hormone Biosynthesis	1.46E+00	1.43E-01	CTSDLipid Antigen Presentation by CD1	1.43E+00	6.67E-02	"B2M,FCER1G"iCOS-iCOSL Signaling in T Helper Cells	1.42E+00	3.17E-02	"PTPRC,HLA-DRA,FCER1G,HLA-DRB1"IL-15 Production	1.40E+00	6.45E-02	"IL6,JAK3"Erythropoietin Signaling	1.35E+00	3.80E-02	"FOS,PTPN6,PRKCB"Heme Degradation	1.33E+00	9.09E-02	HMOX1Arginine Degradation I (Arginase Pathway)	1.33E+00	7.69E-02	ARG1Agrin Interactions at Neuromuscular Junction	1.33E+00	4.29E-02	"MAP2K4,ITGB2,MAPK8"Remodeling of Epithelial Adherens Junctions	1.33E+00	4.29E-02	"TUBB3,DNM1L,TUBB"CCR3 Signaling in Eosinophils	1.32E+00	2.99E-02	"CFL1,CCL11,LIMK1,PRKCB"Melatonin Signaling	1.30E+00	3.70E-02	"MAP2K4,MAP2K6,PRKCB"Renal Cell Carcinoma Signaling	1.30E+00	3.80E-02	"FOS,TGFB1,UBC"4-1BB Signaling in T Lymphocytes	1.29E+00	5.56E-02	"MAP2K4,MAPK8"Small Cell Lung Cancer Signaling	1.29E+00	3.19E-02	"MYC,PTGS2,CCND1"Gαi Signaling	1.25E+00	2.96E-02	"CCR4,CXCR2,P2RY12,STAT3"Catecholamine Biosynthesis	1.24E+00	6.25E-02	THCitrulline-Nitric Oxide Cycle	1.24E+00	6.25E-02	NOS2RhoA Signaling	1.24E+00	3.12E-02	"IGF1,MYL2,CFL1,LIMK1"PI3K/AKT Signaling	1.24E+00	2.63E-02	"PPP2CA,PTGS2,JAK3,CCND1"FLT3 Signaling in Hematopoietic Progenitor Cells	1.23E+00	3.80E-02	"STAT6,CREB1,STAT3"Circadian Rhythm Signaling	1.22E+00	5.26E-02	"GRIN2A,CREB1"Role of JAK2 in Hormone-like Cytokine Signaling	1.22E+00	5.41E-02	"PTPN6,STAT3"BMP signaling pathway	1.22E+00	3.49E-02	"MAP2K4,CREB1,MAPK8"Calcium Signaling	1.20E+00	2.30E-02	"GRIN2A,MYL2,CREB1,MEF2C,MEF2B"Cell Cycle Regulation by BTG Family Proteins	1.19E+00	5.13E-02	"PPP2CA,CCND1"Urea Cycle	1.16E+00	5.00E-02	ARG1Arginine Degradation VI (Arginase 2 Pathway)	1.16E+00	6.25E-02	ARG1Regulation of Actin-based Motility by Rho	1.13E+00	3.26E-02	"MYL2,CFL1,LIMK1"Docosahexaenoic Acid (DHA) Signaling	1.11E+00	4.00E-02	"IL1B,APP"Breast Cancer Regulation by Stathmin1	1.10E+00	2.34E-02	"TUBB3,PPP2CA,TUBB,LIMK1,PRKCB"Relaxin Signaling	1.10E+00	2.44E-02	"FOS,CREB1,NOS2,MMP9"Adenine and Adenosine Salvage III	1.10E+00	5.88E-02	HPRT1Melanocyte Development and Pigmentation Signaling	1.09E+00	3.16E-02	"PTPN6,SOX10,CREB1"CDK5 Signaling	1.07E+00	3.09E-02	"BDNF,PPP2CA,EGR1"UVA-Induced MAPK Signaling	1.03E+00	3.06E-02	"MAP2K4,FOS,MAPK8"Epithelial Adherens Junction Signaling	1.02E+00	2.60E-02	"TUBB3,TGFBR1,MYL2,TUBB"Role of RIG1-like Receptors in Antiviral Innate Immunity	1.02E+00	4.08E-02	"IFIH1,CASP8"VEGF Signaling	1.02E+00	2.75E-02	"PTPN6,EIF2S1,PRKCB"Glioblastoma Multiforme Signaling	1.02E+00	2.38E-02	"MYC,IGF1,AXIN1,CCND1"Glioma Signaling	9.91E-01	2.65E-02	"IGF1,CCND1,PRKCB"SAPK/JNK Signaling	9.91E-01	2.86E-02	"MAP2K4,MAPK8,FCER1G"GABA Receptor Signaling	9.74E-01	3.57E-02	"UBQLN1,UBC"Amyloid Processing	9.16E-01	3.28E-02	"BACE1,APP"Semaphorin Signaling in Neurons	9.02E-01	3.70E-02	"CFL1,LIMK1"Primary Immunodeficiency Signaling	9.02E-01	3.12E-02	"PTPRC,JAK3"Dopamine-DARPP32 Feedback in cAMP Signaling	8.95E-01	2.14E-02	"GRIN2A,PPP2CA,CREB1,PRKCB"NGF Signaling	8.77E-01	2.46E-02	"MAP2K4,CREB1,MAPK8"Choline Biosynthesis III	8.45E-01	4.55E-02	HMOX1Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	8.35E-01	2.52E-02	"AXIN1,STAT3,JAK3"Phospholipases	8.25E-01	2.94E-02	"CCR1,HMOX1"Chondroitin Sulfate Degradation (Metazoa)	8.15E-01	4.35E-02	Chil3/Chil4ErbB4 Signaling	8.02E-01	2.90E-02	"ADAM17,PRKCB"Leukotriene Biosynthesis	7.88E-01	3.85E-02	ALOX5Dermatan Sulfate Degradation (Metazoa)	7.88E-01	4.35E-02	Chil3/Chil4Synaptic Long Term Potentiation	7.72E-01	2.31E-02	"GRIN2A,CREB1,PRKCB"p70S6K Signaling	7.72E-01	2.27E-02	"PPP2CA,IL4,PRKCB"Granzyme B Signaling	7.62E-01	5.56E-02	CASP8Fatty Acid α-oxidation	7.62E-01	4.35E-02	PTGS2Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	7.48E-01	2.63E-02	"IFNG,CCL5"Protein Ubiquitination Pathway	7.36E-01	1.85E-02	"B2M,IFNG,HSPB2,UBC,HSPB1"PXR/RXR Activation	7.28E-01	2.17E-02	"IL6,TNF"Mitotic Roles of Polo-Like Kinase	7.28E-01	2.70E-02	"PPP2CA,TGFB1"Retinoic acid Mediated Apoptosis Signaling	7.28E-01	2.74E-02	"IFNG,CASP8"Ethanol Degradation IV	7.16E-01	3.45E-02	CATPEDF Signaling	6.90E-01	2.53E-02	"BDNF,CASP8"GADD45 Signaling	6.75E-01	4.17E-02	CCND1NF-κB Activation by Viruses	6.63E-01	2.41E-02	"ITGB2,PRKCB"Leptin Signaling in Obesity	6.55E-01	2.35E-02	"NPY,STAT3"VEGF Family Ligand-Receptor Interactions	6.46E-01	2.27E-02	"FOS,PRKCB"Dopamine Receptor Signaling	6.46E-01	2.08E-02	"TH,PPP2CA"D-myo-inositol-5-phosphate Metabolism	6.40E-01	1.85E-02	"PTPRC,CCR1,PTPN6"Polyamine Regulation in Colon Cancer	6.39E-01	3.33E-02	MYCMaturity Onset Diabetes of Young (MODY) Signaling	6.22E-01	3.03E-02	GAPDHRole of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza	6.22E-01	2.41E-02	"IFNG,AXIN1"Actin Cytoskeleton Signaling	6.08E-01	1.65E-02	"MYL2,CFL1,CD14,LIMK1"Role of Lipids/Lipid Rafts in the Pathogenesis of Influenza	6.06E-01	3.45E-02	IFNGProstate Cancer Signaling	5.91E-01	1.94E-02	"CREB1,CCND1"Aldosterone Signaling in Epithelial Cells	5.69E-01	1.78E-02	"HSPB2,HSPB1,PRKCB"Gap Junction Signaling	5.53E-01	1.66E-02	"TUBB3,TUBB,PRKCB"Pyrimidine Ribonucleotides Interconversion	5.48E-01	2.50E-02	ENTPD1"D-myo-inositol (1,4,5)-Trisphosphate Biosynthesis"	5.36E-01	2.50E-02	CCR1Pyrimidine Ribonucleotides De Novo Biosynthesis	5.23E-01	1.85E-02	ENTPD1p53 Signaling	4.92E-01	1.77E-02	"MAPK8,CCND1"TWEAK Signaling	4.89E-01	2.56E-02	CASP8Interferon Signaling	4.79E-01	2.78E-02	IFNGTelomerase Signaling	4.75E-01	1.89E-02	"MYC,PPP2CA"RhoGDI Signaling	4.72E-01	1.49E-02	"MYL2,CFL1,LIMK1"CREB Signaling in Neurons	4.68E-01	1.45E-02	"GRIN2A,CREB1,PRKCB"Notch Signaling	4.40E-01	2.33E-02	ADAM17fMLP Signaling in Neutrophils	4.33E-01	1.52E-02	"NCF1,PRKCB"Sphingosine-1-phosphate Signaling	4.28E-01	1.63E-02	"CASP1,CASP8"Mechanisms of Viral Exit from Host Cells	4.22E-01	2.22E-02	PRKCBTranscriptional Regulatory Network in Embryonic Stem Cells	4.22E-01	2.33E-02	STAT3Androgen Signaling	4.18E-01	1.38E-02	"CCND1,PRKCB"Superpathway of Inositol Phosphate Compounds	4.10E-01	1.28E-02	"PTPRC,CCR1,PTPN6"Thrombin Signaling	4.07E-01	1.42E-02	"MYL2,CREB1,PRKCB"mTOR Signaling	4.07E-01	1.41E-02	"HMOX1,PPP2CA,PRKCB"Melanoma Signaling	4.06E-01	2.00E-02	CCND1Hereditary Breast Cancer Signaling	4.00E-01	1.49E-02	"UBC,CCND1"PTEN Signaling	3.91E-01	1.44E-02	"TGFBR1,CCND1""D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis"	3.70E-01	1.39E-02	"PTPRC,PTPN6""D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis"	3.70E-01	1.39E-02	"PTPRC,PTPN6"eNOS Signaling	3.38E-01	1.29E-02	"CASP8,AQP4"CNTF Signaling	3.36E-01	1.75E-02	STAT3Lymphotoxin β Receptor Signaling	3.25E-01	1.61E-02	LTBRRole of CHK Proteins in Cell Cycle Checkpoint Control	3.19E-01	1.69E-02	PPP2CARegulation of Cellular Mechanics by Calpain Protease	3.08E-01	1.37E-02	CCND13-phosphoinositide Degradation	3.07E-01	1.23E-02	"PTPRC,PTPN6"Superpathway of Melatonin Degradation	2.93E-01	1.23E-02	MPORegulation of eIF4 and p70S6K Signaling	2.82E-01	1.14E-02	"PPP2CA,EIF2S1"Gαq Signaling	2.82E-01	1.17E-02	"HMOX1,PRKCB"Antiproliferative Role of Somatostatin Receptor 2	2.74E-01	1.39E-02	PTPN63-phosphoinositide Biosynthesis	2.70E-01	1.10E-02	"PTPRC,PTPN6"Non-Small Cell Lung Cancer Signaling	2.69E-01	1.20E-02	CCND1Hypoxia Signaling in the Cardiovascular System	2.65E-01	1.47E-02	CREB1Basal Cell Carcinoma Signaling	2.36E-01	1.28E-02	AXIN1